Caplin Point Laboratories DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.80×	0.81×	0.80×	0.82×	0.84×
	1.17×	1.17×	1.16×	1.13×	1.14×
	31.4%	31.5%	30.0%	29.4%	27.0%
	0.60×	0.60×	0.66×	0.69×	0.75×
	1.11×	1.11×	1.11×	1.15×	1.15×
	19.8%	19.9%	20.5%	21.6%	22.1%
	19.9%	19.9%	21.8%	21.8%	22.4%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

CAPLIPOINT₹2,376.10

Caplin Point Laboratories Ltd.

· Pharma & Health

₹ CrorePeersAJANTPHARM ERIS GLAND BLUEJET CONCORDBIO ACUTAAS EMCURE GRANULESMcap ₹18,058 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.84	0.82	0.80	0.81	0.80
Interest Burden (Pretax/EBIT) ×	1.14	1.13	1.16	1.17	1.17
EBIT Margin %	27.00	29.40	29.99	31.46	31.41
Asset Turnover ×	0.75	0.69	0.66	0.60	0.60
Financial Leverage (Assets/Equity) ×	1.15	1.15	1.11	1.11	1.11
ROE (5-step product, year-end total equity) %	22.15	21.60	20.49	19.86	19.82
ROE (owners' profit / average owners' equity) %	22.37	21.79	21.81	19.92	19.92

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.